Reactive oxygen species stimulate p44/42 mitogen-activated protein kinase and induce p27(Kip1): Role in angiotensin II-mediated hypertrophy of proximal tubular cells

Journal of the American Society of Nephrology

Volumn 11, Issue 8, 2000, Pages 1387-1397

  Hannken, Tete ^a   Schroeder, Regine ^a   Zahner, Gunther ^a   Stahl, Rolf A K ^a   Wolf, Gunter ^a,b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANGIOTENSIN; CYCLIN DEPENDENT KINASE INHIBITOR; DIPHENYLENE IODINIUM; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P27; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME ACTIVATION; ENZYME INHIBITION; KIDNEY HYPERTROPHY; KIDNEY PROXIMAL TUBULE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION;

EID: 0033927997     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Wolf G, Neilson EG: Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am J Physiol 259: F768-F777, 1990
2. 1 receptor. Nephrol Dial Transplant 8: 128-133, 1993
3. Kip1. Kidney Int 50: 2112-2119, 1996
4. Kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals. Kidney Int 54: 1923-1933, 1998
5. Griendling KK, Ushio-Fukai M: Redox control of vascular smooth muscle proliferation. J Lab Clin Med 132: 9-15, 1998
6. - in vascular smooth muscle cells. Cir Res 77: 29-36, 1995
7. Kanterewicz BI, Knapp LT, Klann E: Stimulation of p42 and p44 mitogen-activated protein kinases by reactive oxygen species and nitric oxide in hippocampus. J Neurochem 70: 1009-1016, 1998
8. Haverty TP, Kelly CJ, Hines WH, Amenta PS, Watanabe M, Harper RA, Kefalides NA, Neilson EG: Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. J Cell Biol 107: 1359-1368, 1988
9. 1. In Vitro 12: 670-677, 1976
10. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR: PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinases kinase in vitro and in vivo. J Biol Chem 270: 27489-27494, 1995
11. Wolf G, Ziyadeh FN, Zahner G, Stahl RAK: Angiotensin II is mitogenic for cultured rat glomerular endothelial cells. Hypertension 27: 897-905, 1996
12. Kawata Y, Mizukami Y, Fujii Z, Sakumura T, Yoshida K, Matsuzaki M: Applied pressure enhances cell proliferation through mitogen-activated protein kinase activation in mesangial cells. J Biol Chem 273: 16905-16912, 1998
13. Brenner BM: Nephron adaptation to renal injury or ablation. Am J Physiol 249: F324-F337, 1985
14. Wolf G, Neilson EG: Molecular mechanisms of tubulointerstitial hypertrophy and hyperplasia. Kidney Int 39: 401-420, 1991
15. Fine L, Ong ACN, Norman JT: Mechanisms of tubulointerstitial injury in progressive renal disease. Eur J Clin Invest 23: 259-265, 1993
16. 1 receptor inhibits angiotensin II stimulated DNA and protein synthesis in primary cultures of human proximal tubular cells. Kidney Int 51: 699-705, 1997
17. Harris RC: Regulation of S6 kinase activity in renal proximal tubule. Am J Physiol 263: F127-F134, 1992
18. Terada Y, Tomita K, Homma MW, Nonoguchi H, Yang T, Yamada T, Yuasa Y, Krebs EG, Marumo F: Sequential activation of MAP kinase cascade by angiotensin II in opossum kidney cells. Kidney Int 48: 1801-1809, 1995
19. Terada Y, Yamada T, Takayama M, Nonoguchi H, Sasaki S, Tomita K, Marumo F: Presence and regulation of Raf-1-K (kinase), MAPK-K, MAP-K, and S6-K in rat nephron segments. J Am Soc Nephrol 6: 1565-1577, 1995
20. Huwiler A, Stabel S, Fabbro D, Pfeilschifter J: Platelet-derived growth factor and angiotensin II stimulate the mitogen-activated protein kinase cascade in renal mesangial cells: Comparison of hypertrophie and hyperplastic agonists. Biochem J 305: 777-784, 1995
21. Callsen D, Pfeilschifter J, Brüne B: Rapid and delayed p42/44 mitogen-activated protein kinase activation by nitric oxide: The role of cyclic GMP and tyrosine phosphatase inhibition. J Immunol 161: 4852-4858, 1998
22. Wolf G, Ziyadeh FN, Schroeder R, Stahl RAK: Angiotensin II inhibits inducible nitric oxide synthase in tubular MCT cells by a posttranscriptional mechanism. J Am Soc Nephrol 8: 551-557, 1997
23. Wang D, Yu X, Brecher P: Nitric oxide and N-acetylcysteine inhibit the activation of mitogen-activated protein kinases by angiotensin in rat cardiac fibroblasts. J Biol Chem 273: 33027-33034, 1998
24. 2, but not by carbachol, in rat pheochromocytoma PC12 cells. J Neurochem 71: 2278-2285, 1998
25. 2. J Biol Chem 273: 32554-32560, 1998
26. Karin M: The regulation of API activity by mitogen-activated protein kinases. J Biol Chem 270: 16483-16486, 1995
27. Bornfeldt KE, Campbell JS, Koyama H, Argast GM, Leslie CG, Raines EW, Krebs EG, Ross R: The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells: Dependence on the availability of downstream targets. J Clin Invest 100: 875-885, 1997
28. Pumiglia KM, Decker SJ: Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 94: 448-452, 1997
29. Cip1. Mol Cell Biol 17: 5598-5611, 1997
30. Tombes RM, Auer KL, Mikkelsen R, Valerie K, Wymann MP, Marshall CJ, McMahon M, Dent P: The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic. Biochem J 330: 1451-1460, 1998
31. Wolf G, Mueller E, Stahl RAK, Ziyadeh FN: Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-β. J Clin Invest 92: 1366-1372, 1993
32. Hamaguchi A, Kim S, Izumi Y, Zhan Y, Yamanaka S, Iwao H: Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-β1 expression in vascular smooth muscle cells. Hypertension 34: 126-131, 1999
33. Yu SJ, Boundreau F, Désilets A, Houde M, Rivard N, Asselin C: Attenuation of haptoglobin gene expression by TGF-β requires the MAP kinase pathway. Biochem Biophys Res Commun 259: 544-549, 1999
34. Force T, Bonventre JV: Growth factors and mitogen-activated protein kinases. Hypertension 31: 152-161, 1998
35. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK: p38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 273: 15022-15029, 1998
36. + exchange and ERK1/2. Circ Res 83: 824-831, 1998
37. Alessandrini A, Chiaur DS, Pagano M: Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation. Leukemia 11: 342-345, 1997
38. Kip1. EMBO J 16: 5334-5344, 1997
39. Bokemeyer D, Sorokin A, Dunn MJ: Multiple intracellular MAP kinase signaling cascades. Kidney Int 49: 1187-1198, 1996
40. Bonventre JV, Force T: Mitogen-activated protein kinases and transcriptional responses in renal injury and repair. Curr Opin Nephrol Hypertens 7: 425-433, 1998